SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63388 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61293As you noted, that paper is 10 years old. I guess I'm just trying to reconcweatherproof-11/14/2022
61292endpts.comsysiphus-11/14/2022
61291Interestingly, this study does not identify the misfolded variety of FLNA. I imaghettogoulash-11/13/2022
61290The company puts more of an emphasis on eliminating the toxic signaling of AB42-ghettogoulash-11/13/2022
61289By the way, I'm wondering if some of you SAVAges can weigh in on my sense thweatherproof211/13/2022
61288>>And yes, they are indeed biomarkers. But what good is early diagnosis ofweatherproof-11/13/2022
61287I can only speak for Simufilam and similar nouveau research. Maybe Anavex is amoghettogoulash-11/13/2022
61286That post was epic, Fitz. Thanks. It just so happens to fit perfectly with my thghettogoulash-11/13/2022
61285When I think of a treatment that helps reduce production of plaque as well as reweatherproof211/12/2022
61284Up 7%. Biggest dollar gain in a single day for me other than when IMMU got bougstockdoc77811/10/2022
61283Dearest Ghetto: I think that many of your inferences are correct. As you mayFitzhughlaw1611/10/2022
61282On a related note, I've been wondering what preliminary evidence Cassava hasghettogoulash111/9/2022
61281A few points regarding Anavex. CEO, Christopher Missling will present at Guggenweatherproof-11/9/2022
61280PAVM Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volumerickerickson-11/9/2022
61279Encouraging news from ADAP today. finance.yahoo.comStikkmann-11/8/2022
61278"We think we know what's going on here" Actually the analyst'ghettogoulash-11/8/2022
61277New AVXL article from SA actually shows data, some of which is of real promise ascorman1-11/8/2022
61276Fitz, after your comments about Mr. Cook, I almost posted here asking what you tghettogoulash-11/8/2022
61275Duh. Thanks for the correction.ghettogoulash-11/7/2022
61274I don't know what you mean by "plea bargaining," which only occursFitzhughlaw211/7/2022
61273SAVA releases Q3 results. SAVA Results Expectations of Open Label at end of 2Davidoff-11/7/2022
61272AVXL finance.yahoo.comsysiphus-11/7/2022
61271I am lmao thinking about the caliber of attorneys these clowns can even afford. ghettogoulash-11/7/2022
61270Schwab has been steadily dropping the SAVA rate, 14.5% yesterday. Here's a erickerickson211/5/2022
61269Etrade was 17.694 as of yesterdayerippetoe-11/4/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News